Follow
Shuang Yan, MD, Ph.D
Shuang Yan, MD, Ph.D
Massachusetts General Hospital, Harvard Medical School
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
β-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma
S Yan, C Zhou, W Zhang, G Zhang, X Zhao, S Yang, Y Wang, N Lu, H Zhu, ...
Cancer letters 271 (1), 85-97, 2008
1262008
Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo
S Yan, Z Li, CJ Thiele
Oncotarget 4 (3), 433, 2013
1062013
Combination of an allosteric Akt Inhibitor MK-2206 with etoposide or rapamycin enhances the antitumor growth effect in neuroblastoma
Z Li, S Yan, N Attayan, S Ramalingam, CJ Thiele
Clinical Cancer Research 18 (13), 3603-3615, 2012
772012
PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma
S Yan, C Zhou, X Lou, Z Xiao, H Zhu, Q Wang, Y Wang, N Lu, S He, ...
Cancer research 69 (8), 3283-3290, 2009
702009
Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity
S Odate, V Veschi, S Yan, N Lam, R Woessner, CJ Thiele
Clinical Cancer Research 23 (7), 1771-1784, 2017
652017
EB1 acts as an oncogene via activating β‐catenin/TCF pathway to promote cellular growth and inhibit apoptosis
M Liu, S Yang, Y Wang, H Zhu, S Yan, W Zhang, L Quan, J Bai, N Xu
Molecular Carcinogenesis: Published in cooperation with the University of …, 2009
442009
Suppression of Aurora-A oncogenic potential by c-Myc downregulation
S Yang, S He, X Zhou, M Liu, H Zhu, Y Wang, W Zhang, S Yan, L Quan, ...
Experimental & molecular medicine 42 (11), 759-767, 2010
422010
β-catenin/TCF pathway plays a vital role in selenium induced-growth inhibition and apoptosis in esophageal squamous cell carcinoma (ESCC) cells
W Zhang, S Yan, M Liu, G Zhang, S Yang, S He, J Bai, L Quan, H Zhu, ...
Cancer letters 296 (1), 113-122, 2010
362010
Aurora kinase A induces miR-17-92 cluster through regulation of E2F1 transcription factor
S He, S Yang, G Deng, M Liu, H Zhu, W Zhang, S Yan, L Quan, J Bai, ...
Cellular and molecular life sciences 67, 2069-2076, 2010
302010
P21-activated kinase 7 mediates cisplatin-resistance of esophageal squamous carcinoma cells with Aurora-A overexpression
S He, M Feng, M Liu, S Yang, S Yan, W Zhang, Z Wang, C Hu, Q Xu, ...
PLoS One 9 (12), e113989, 2014
262014
Dihydropyrimidinase‐like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma
F Tan, R Wahdan‐Alaswad, S Yan, CJ Thiele, Z Li
Cancer science 104 (12), 1586-1592, 2013
262013
The allosteric Akt inhibitor MK-2206 inhibits neuroblastoma tumor cell growth in vitro and in vivo
Z Li, S Ramalingam, S Yan, CJ Thiele
Cancer Research 71 (8_Supplement), 4342-4342, 2011
12011
Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150 increases the chemosensitivity and decreases tumor-initiating potential of neuroblastoma cells
S Odate, S Yan, V Veschi, N Lam, Z Liu, CJ Thiele
Cancer Research 76 (14_Supplement), 2439-2439, 2016
2016
Inhibition of STAT3 sensitizes neuroblastoma xenografts cells to Etoposide
S Yan, C Thiele
Cancer Research 74 (19_Supplement), 4736-4736, 2014
2014
Validation of potential therapeutic targeting of IL-6/JAK/STAT3 pathway by AZD1480 in neuroblastoma and other pediatric tumors
S Yan, CJ Thiele
Cancer Research 72 (8_Supplement), 1440-1440, 2012
2012
PTTG promotes lymph node metastasis in human esophageal squamous cell carcinoma
S Yan, C Zhou, L Quan, X Lou, S He, J Bai, H Zhu, N Xu
Cancer Research 68 (9_Supplement), 350-350, 2008
2008
Supplemental Table
T LB
Cell 20, 40, 0
The system can't perform the operation now. Try again later.
Articles 1–17